Article Versions Notes

Massimino M, Vigneri P, Stella S, Tirrò E, Pennisi MS, Parrinello LN, Vetro C, Manzella L, Stagno F, Di Raimondo F. Combined Inhibition of Bcl2 and Bcr-Abl1 Exercises Anti-Leukemia Activity but Does Not Eradicate the Primitive Leukemic Cells. Journal of Clinical Medicine. 2021; 10(23):5606. https://doi.org/10.3390/jcm10235606

Massimino, Michele, Paolo Vigneri, Stefania Stella, Elena Tirrò, Maria Stella Pennisi, Laura Nunziatina Parrinello, Calogero Vetro, Livia Manzella, Fabio Stagno, and Francesco Di Raimondo. 2021. "Combined Inhibition of Bcl2 and Bcr-Abl1 Exercises Anti-Leukemia Activity but Does Not Eradicate the Primitive Leukemic Cells" Journal of Clinical Medicine 10, no. 23: 5606. https://doi.org/10.3390/jcm10235606

Massimino, M., Vigneri, P., Stella, S., Tirrò, E., Pennisi, M. S., Parrinello, L. N., Vetro, C., Manzella, L., Stagno, F., & Di Raimondo, F. (2021). Combined Inhibition of Bcl2 and Bcr-Abl1 Exercises Anti-Leukemia Activity but Does Not Eradicate the Primitive Leukemic Cells. Journal of Clinical Medicine, 10(23), 5606. https://doi.org/10.3390/jcm10235606